Cationic peptides: Effectors in innate immunity and novel antimicrobials

Lancet Infectious Diseases

Volumn 1, Issue 3, 2001, Pages 156-164

  Hancock, Robert Ew ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CATION; GRAMICIDIN; POLYMYXIN B; TOPICAL ANTIINFECTIVE AGENT;

AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; MOLECULAR GENETICS; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; CATIONS; GRAMICIDIN; HUMANS; IMMUNITY, NATURAL; MOLECULAR SEQUENCE DATA; POLYMYXIN B;

EID: 0035496012     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(01)00092-5     Document Type: Review

References (52)

1. Waterer G.W., Wunderink R.G. Increasing threat of Gram-negative bacteria. Crit Care Med. 29:(suppl. 4):2001;N75-81.
2. Hancock R.E.W. Cationic antimicrobial peptides: towards clinical applications. Expert Opin Invest Dis. 9:2000;1723-1729.
3. http://www.bbcm.univ.trieste.it/~tossi/pag1.htm (accessed Sept 10, 2001).
4. Ganz T., Lehrer R.I. Antimicrobial peptides of vertebrates. Curr Opin Immunol. 10:1998;41-44.
5. Hancock R.E.W., Lehrer R.I. Cationic peptides: a new source of antibiotics. Trends Biotechnol. 16:1998;82-88.
6. Boman H.G. Peptide antibiotics and their role in innate immunity. Annu Rev Immunol. 13:1995;61-92.
7. Gudmundsson G.H., Agerberth B. Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. J Immunol Methods. 232:1999;45-54.
8. Hancock R.E.W., Diamond G. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8:2000;402-410.
9. Scott M.G., Hancock R.E.W. Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit Rev Immunol. 20:2000;407-431.
10. Raj P.A., Karunakaran T., Sukumaran D.K. Synthesis, microbicidal activity, and solution structure of the dodecapeptide from bovine neutrophils. Biopolymers. 53:2000;281-292.
11. http://www.cmdr.ubc.ca/bobh/MIC.htm (accessed Sept 10, 2001).
12. Yan H., Hancock R.E.W. Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob Agents Chemother. 45:2001;1558-1560.
13. Harder J., Bartels J., Christophers E., Schroeder J.-M. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem. 276:2001;5707-5713.
14. Scott M.G., Yan H., Hancock R.E.W. Biological properties of structurally related α-helical cationic antimicrobial peptides. Infect Immun. 67:1999;2005-2009.
15. Zhang L., Scott M.G., Yan H., Mayer L.D., Hancock R.E.W. Interaction of polyphemusin I and structural analogs with bacterial membranes, lipopolysaccharide and lipid monolayers. Biochemistry. 39:2000;14504-14514.
16. Chan Y.R., Gallo R.L. PR-39, a syndecan-inducing antimicrobial peptide, binds and affects p130(Cas). J Biol Chem. 273:1998;28978-28985.
17. Steinberg D.A., Hurst M.A., Fujii C.A., et al. Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob Agents Chemother. 41:1997;1738-1742.
18. Wu M., Hancock R.E.W. Improved derivatives of bactenecin, a cyclic dodecameric antimicrobial cationic peptide. Antimicrob Agents Chemother. 43:1999;1274-1276.
19. Groisman E.A., Aspedon A. The genetic basis of microbial resistance to antimicrobial peptides. Methods Mol Biol. 78:1997;205-215.
20. Ernst R.K., Yi E.C., Guo L., et al. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science. 286:1999;1561-1565.
21. MacFarlane E.L.A., Kwasnicka A., Hancock R.E.W. Role of Pseudomonas aeruginosa PhoP-PhoQ in resistance to antimicrobial peptides and aminoglycosides. Microbiology. 146:2000;2543-2554.
22. Friedrich C.L., Moyles D., Beveridge T.J., Hancock R.E.W. Antibacterial action of structurally diverse cationic peptides on Gram-positive bacteria. Antimicrob Agents Chemother. 44:2000;2086-2092.
23. De Samblanx G.W., Goderis I.J., Thevissen K., et al. Mutational analysis of a plant defensin from radish (Raphanus sativus L) reveals two adjacent sites important for antifungal activity. J Biol Chem. 272:1997;1171-1179.
24. Helmerhorst E.J., Breeuwer P., van't Hof W., et al. The cellular target of histatin 5 on Candida albicans is the energized mitochondrion. J Biol Chem. 274:1999;7286-7291.
25. Giacometti A., Cirioni O., Barchiesi F., Caselli F., Scalise G. In-vitro activity of polycationic peptides against Cryptosporidium parvum, Pneumocystis carinii and yeast clinical isolates. J Antimicrob Chemother. 44:1999;403-406.
26. Jaynes J.M., Burton C.A., Barr S.B., et al. In vitro cytocidal effect of novel lytic peptides on Plasmodium falciparum. FASEB J. 2:1998;2878-2883.
27. Chalk R., Townson H., Ham P.J. Brugia pahangi: the effects of cecropins on microfilariae in vitro and in Aedes aegypti. Exp Parasitol. 80:1995;401-406.
28. Soballe P.W., Maloy W.L., Myrga M.L., Jacob L.S., Herlyn M. Experimental local therapy of human melanoma with lytic magainin peptides. Int J Cancer. 60:1995;280-284.
29. Peck-Miller K.A., Blake J., Cosand W.L., Darveau R.P., Fell H.P. Structure-activity analysis of the antitumor and hemolytic properties of the amphiphilic α-helical peptide, C18G. Int J Pept Protein Res. 44:1994;143-151.
30. Zhang L., Hancock R.E.W. Peptide antibiotics. Hughes D., Andersson D.I. Antibiotic resistance and antibiotic development. 2000;209-232 Harwood Academic Publishers, Reading.
31. Matsuzaki K., Mitani Y., Akada K.Y., et al. Mechanism of synergism between antimicrobial peptides magainin 2 and PGLa. Biochemistry. 37:1998;15144-15153.
32. Hancock R.E.W., Chapple D.S. Peptide antibiotics. Antimicrob Agents Chemother. 43:1999;1317.
33. Huang H.W. Action of antimicrobial peptides: two-state model. Biochemistry. 39:2000;8347-8352.
34. Matsuzaki K. Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim Biophys Acta. 1376:1998;391-400.
35. Oren Z., Shai Y. Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Biopolymers. 47:1998;451-463.
36. Piers K.L., Brown M.H., Hancock R.E.W. Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria. Gene. 134:1993;7-13.
37. Tsubery H., Ofek I., Cohen S., Fridkin M. Structure-function studies of polymyxin B nonapeptide: implications to sensitization ofgram-negative bacteria. J Med Chem. 43:2000;3085-3092.
38. Wu M., Maier E., Benz R., Hancock R.E.W. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry. 38:1999;7235-7242.
39. Park C.B., Yi K.S., Matsuzaki K., Kim M.S., Kim S.C. Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. Proc Natl Acad Sci USA. 97:2000;8245-8250.
40. Andreu D., Rivas L. Animal antimicrobial peptides: an overview. Biopolymers. 47:1998;415-433.
41. Meister M., Hetru C., Hoffmann J.A. The antimicrobial host defense of Drosophila. Curr Top Microbiol Immunol. 248:2000;17-36.
42. Wilson C.L., Ouellette A.J., Satchell D.P., et al. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science. 286:1999;113.
43. Cole A.M., Shi J., Ceccarelli A., et al. Inhibition of neutrophil elastate prevents cathelicidin activation and impairs clearance of bacteria from wounds. Blood. 97:2001;297-304.
44. Bals R., Weiner D.J., Moscioni A.D., Meegalla R.L., Wilson J.M. Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect Immun. 67:1999;6084-6089.
45. Cole A.M., Dewan P., Ganz T. Innate antimicrobial activity of nasal secretions. Infect Immun. 67:1999;3267-3275.
46. Singh P.K., Jia H.P., Wiles K., et al. Production of β-defensins by human airway epithelia. Proc Natl Acad Sci USA. 95:1998;14961-14966.
47. Yang D.e, Chen Q., Schmidt A.P., et al. LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes and T cells. J Exp Med. 192:2000;1069-1074.
48. Scott M.G., Rosenberger C.M., Gold M.R., Finlay B.B., Hancock R.E.W. An α-helical cationic antimicrobial peptide selectively modulates macrophage response to LPS and directly alters macrophage gene expression. J Immunol. 165:2000;3358-3365.
49. Wanecek M., Weitzberg E., Rudehill A., Oldner A. The endothelin system in septic and endotoxin shock. Eur J Pharmacol. 407:2000;1-15.
50. Hancock R.E.W., Scott M.G. The role of antimicrobial peptides in animal defences. Proc Natl Acad Sci USA. 97:2000;8856-8861.
51. Owens L.D., Heutte T.M. A single amino acid substitutionin the antimicrobial defense protein cecropin B is associatedwith diminished degradation by leaf intracellular fluid. Mol Plant Microbe Interact. 10:1997;525-528.
52. Varbanac D., Zanetti M., Romeo D. Chemotactic andprotease-inhibiting activities of antibiotic peptide precursors. FEBS Lett. 317:1993;255-258.